Most people know about type 1 and type 2 diabetes, but there are actually several distinct types, each with different causes and different approaches to management. Globally, about 589 million adults live with some form of diabetes, affecting roughly 11% of the adult population. Here’s a breakdown of every major type and what sets them apart.
Type 1 Diabetes
Type 1 diabetes is an autoimmune disease. The immune system’s T-cells mistakenly attack and destroy the insulin-producing beta cells in the pancreas. Without those cells, the body can’t make insulin at all, so people with type 1 need to take insulin every day for life. It’s usually diagnosed in children and young adults, though it can appear at any age. Type 1 accounts for about 5% of all diabetes cases.
Because the destruction of beta cells happens relatively quickly, symptoms tend to come on fast: extreme thirst, frequent urination, unexpected weight loss, and fatigue. Unlike type 2, type 1 has nothing to do with diet or lifestyle. The exact trigger is still unclear, but genetics and certain viral infections likely play a role.
Type 2 Diabetes
Type 2 is by far the most common form, making up roughly 90 to 95% of all cases. In type 2, the body still produces insulin, but cells gradually stop responding to it properly. This is called insulin resistance. The pancreas tries to compensate by pumping out more insulin, but over time it can’t keep up, and blood sugar stays elevated.
Risk factors include excess body weight, physical inactivity, a family history of diabetes, and age (risk rises after 35, though younger diagnoses are increasing). Type 2 develops slowly, sometimes over years, so many people have it without realizing. Early management often involves changes to diet and physical activity, sometimes combined with oral medications. Some people with type 2 eventually need insulin as well, particularly if the condition progresses.
Prediabetes
Prediabetes isn’t a separate disease, but it’s worth understanding as a warning stage. It means blood sugar levels are higher than normal but not yet high enough for a diabetes diagnosis. According to the American Diabetes Association, prediabetes is defined as an A1C between 5.7% and 6.4%, a fasting blood sugar of 100 to 125 mg/dL, or a two-hour glucose tolerance result of 140 to 199 mg/dL.
Without intervention, prediabetes frequently progresses to type 2. The good news is that modest weight loss (5 to 7% of body weight) and regular physical activity can significantly reduce that risk or even reverse prediabetes entirely.
Gestational Diabetes
Gestational diabetes develops during pregnancy in people who didn’t have diabetes before. Hormones produced by the placenta make cells more resistant to insulin, and if the pancreas can’t produce enough extra insulin to overcome that resistance, blood sugar rises. It typically appears in the second or third trimester and is detected through routine screening between weeks 24 and 28.
For most people, gestational diabetes resolves after delivery. However, having it once raises the long-term risk of developing type 2 diabetes later in life by roughly 50%. Management during pregnancy usually involves monitoring blood sugar, adjusting diet, staying active, and in some cases taking insulin.
LADA (Latent Autoimmune Diabetes in Adults)
Sometimes called type 1.5, LADA is an autoimmune form of diabetes that shows up in adulthood, typically after age 30. Like type 1, the immune system attacks the pancreas’s beta cells. But the destruction happens much more slowly, which is why LADA is often misdiagnosed as type 2 at first. People with LADA may manage fine on oral medications initially, then find their blood sugar becomes harder to control over months or years as their pancreas gradually loses the ability to produce insulin.
The key diagnostic tool is a blood test that looks for GAD antibodies (proteins that signal an autoimmune attack on beta cells). If those antibodies are present in someone diagnosed with “type 2” who is relatively lean and doesn’t fit the typical profile, LADA is the more likely explanation. Eventually, everyone with LADA needs insulin.
Type 3c (Pancreatogenic) Diabetes
Type 3c diabetes develops when the pancreas is physically damaged by another condition. Chronic pancreatitis is the most common cause, but acute pancreatitis, pancreatic cancer, cystic fibrosis, iron overload (hemochromatosis), and surgical removal of part of the pancreas can also trigger it. The damage impairs the organ’s ability to produce insulin and, in many cases, glucagon as well. Glucagon is the hormone that raises blood sugar when it drops too low, so losing both hormones makes blood sugar especially difficult to manage: it can swing both too high and too low.
Type 3c is frequently misclassified as type 2, which matters because the treatment approach differs. People with type 3c often need insulin earlier and may also need enzyme supplements to help with digestion, since the same damage that disrupts hormone production also affects the pancreas’s digestive function.
Monogenic Diabetes (MODY and Neonatal)
Monogenic diabetes is caused by a mutation in a single gene, unlike type 1 and type 2 which involve multiple genes and environmental factors. It’s rare, accounting for 1 to 4% of all diabetes cases, but it’s clinically important because many people with monogenic diabetes are misdiagnosed and given the wrong treatment.
MODY (Maturity-Onset Diabetes of the Young)
MODY typically appears in adolescence or early adulthood and runs strongly in families, usually affecting multiple generations. There are several subtypes based on which gene is involved. The two most common are HNF1A-MODY, which accounts for 50 to 70% of cases, and GCK-MODY, which accounts for 30 to 50%. A few rarer forms, like HNF4A-MODY and HNF1B-MODY, each represent 5 to 10% of cases.
The treatment depends entirely on the subtype. GCK-MODY causes mildly elevated blood sugar that rarely needs medication at all, just monitoring. HNF1A-MODY responds very well to a class of oral medications, and people with this form often don’t need insulin. This is why genetic testing matters: a person with MODY who’s been put on insulin based on a type 1 or type 2 diagnosis may be able to switch to a simpler, more effective treatment.
Neonatal Diabetes
Neonatal diabetes appears in the first 6 to 12 months of life. Babies diagnosed with diabetes this early almost always have a monogenic form rather than type 1. Some cases are transient (resolving in infancy but sometimes returning later), while others are permanent. Like MODY, some forms of neonatal diabetes respond to oral medications, meaning certain babies initially started on insulin can eventually switch off it.
Drug-Induced (Secondary) Diabetes
Certain medications can push blood sugar high enough to cause diabetes, particularly in people who already have some insulin resistance. Glucocorticoids (steroids like prednisone and dexamethasone, used for inflammation and autoimmune conditions) are the most common culprit. High blood sugar occurs in over one-third of patients treated with glucocorticoids. Other medications linked to elevated blood sugar include certain immunosuppressants, some antipsychotics, and specific blood pressure drugs.
In some cases, blood sugar returns to normal once the medication is tapered or stopped. In others, the drug unmasks an underlying tendency toward diabetes that persists. If you’re starting a long-term course of steroids or another high-risk medication, blood sugar monitoring is a reasonable precaution, especially if you have other risk factors for type 2.
How Diabetes Is Diagnosed
Regardless of type, diabetes is confirmed through blood tests. The American Diabetes Association recognizes three primary methods. An A1C test measures your average blood sugar over the past two to three months: 6.5% or higher indicates diabetes. A fasting blood sugar test checks your level after an overnight fast: 126 mg/dL or higher is diagnostic. An oral glucose tolerance test measures blood sugar two hours after drinking a sugary solution: 200 mg/dL or higher confirms diabetes.
These tests identify that diabetes is present, but they don’t tell you which type. Additional testing, like antibody tests for type 1 or LADA, genetic testing for MODY, or imaging of the pancreas for type 3c, helps pin down the specific form. Getting the type right matters because each one has a different trajectory and responds to different treatments.